2021 Editorial Board Conflicts of Interest

William F. Balistreri, MD, receives grants from Gilead Sciences (HCV & HBV antivirals), Abbvie (HCV antivirals), and Merck (HCV antivirals); serves as a consultant for Digestive Care, Otsuka, and DYNACURE; and serves on the scientific advisory board for Alexion Pharma GmbH and Kadmon Pharmaceuticals, LLC.

Stephen R. Daniels, MD, PhD, serves on the advisory committee for Sanofi (focus on dyslipidemia); serves on the Data Safety and Monitoring Committee for Regeneron (focus on dyslipidemia); and is the Chair of the Data Monitoring Committee for Novo Nordisck (focus on obesity).

Raye-Ann deRegnier, MD, serves as a medical editor for the American Board of Pediatrics.

Paul G. Fisher, MD, serves on the Editorial Board for Journal of Clinical Oncology, Journal of Neuro-Oncology, and Frontiers in Pediatric Oncology; serves on the speakers’ bureau of the American Academy of Pediatrics (<$1,000) and Symposia Medicus <$2,000/year; serves on the data and safety monitoring board for Neurocrine, Inc.; serves as a consultant for Novo Ventures (<$1500 in a single year); receives research grant support from the National Cancer Institute (Pediatric Brain Tumor Consortium; provides salary support); receives research grant support from the National Human Genome Research Institute (Undiagnosed Diseases Network; provides salary support); has stock holdings (<$5,000) from Johnson & Johnson; and has provided expert testimony in a medicolegal case.

Denise M. Goodman, MD, MS, received travel funding from the Society of Critical Care Medicine (2020); receives royalties from Current Procedures: Pediatrics.

Sarah S. Long, MD, is the Editor of Principles and Practice of Pediatric Infectious Diseases 6th edition (Elsevier).

Robin H. Steinhorn, MD, is a consultant for Actelion and Pfizer; and is a member of the Board of Directors for the American Board of Pediatrics.

Thomas R. Welch, MD, owns stocks in Abbott Laboratories, AbbVie Inc, Astra Zeneca, Johnson and Johnson, Pfizer, Merck, and Procter and Gamble; previously served on the scientific advisory board of Alexion.

Jennifer Accardo, MD, MSCE, receives book royalties from Springer Nature and Paul H. Brookes Publishing Co.

María S. Rueda Altez, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

William A. Bonadio, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Terrill Bravender, MD, MPH, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Michael D. Cabana, MD, MPH, is a member of the United States Preventive Services Task Force (USPSTF) (voluntary position).

Mitchell B. Cohen, MD, served as a consultant for the American Cleaning Institute (2015-2018); received grant funding from Ironwood Pharmaceuticals (2015-2017); and served on the Editorial Board for JAMA Pediatrics (2019)

Carlos Cuello-García, MD, is employed by the Canadian Agency for Drugs and Technology in Health (CADTH) as Senior Research Officer; serves on the Editorial Board for The Journal of Clinical Epidemiology and World Allergy Organization Journal; serves as a GRADE expert paid consultant for pediatric guideline development for the American College of Rheumatology (total of $2,000.00 USD) (February 1, 2020-February 1, 2021); serves as a GRADE expert paid consultant for the development of clinical practice guidelines for the American College of Physicians (total of $3,000.00 USD); and serves as a consultant (unpaid) for the World Health Organization Collaborating Center for Infectious Diseases, Research.

Lizhong Du, MD, serves on the Editorial Board of BMC Pediatrics.

Christopher Duggan, MD, MPH, is the Editor-in-Chief of The American Journal of Clinical Nutrition; receives royalties for textbooks from People’s Medical Publishing House USA; and receives royalties for online review articles from UpToDate, Inc.

Michael Duyzend, MD, MPhil, PhD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

E. Vincent Faustino, MD, MHS, receives grant funding from the National Institutes of Health, the American Heart Association, Grifols Shared Services of North America, Inc, and Philippine Department of Science and Technology ; and serves on the Editorial Board for Frontiers in Pediatrics.

William S. Ferguson, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Joseph Flynn, MD, MS, serves as the Editor-in-Chief of Pediatric Nephrology; serves as an Editorial Board member for Hypertension and Blood Pressure Monitoring; receives royalties from Springer, Inc and Up To Date, Inc; and served as a consultant for Vertex Pharmaceuticals (2015-2016), Ultragenyx, Inc (2016-2018), and Silvergate Pharmaceuticals (2018-2019).

Elena Fuentes-Afflick, MD, MPH, serves as an associate editor for Pediatric Research; reports providing input regarding Latino health and Spanish translation of study materials for the Agency for Healthcare Research and Quality; and reports serving as Home Secretary for the National Academy of Medicine and is responsible for the integrity of the election process and other membership issues.

Samuel Gidding, MD, serves on the Editorial Board for Circulation and Hypertension; serves as consultant and principal investigator of a clinical trial of bempedoic acid in children with familial hypercholesterolemia for Esperion; serves on the Science Committee (unpaid) for the World Heart Association; receives research grant support from the National Institutes of Health (TODAY2 [study adolescent type 2 diabetes]; CHARISMA [metabolic risk in southeast Asian children]; and IMPACT-FH [finding patients with familial hypercholesterolemia using IT and genomic technologies]); serves on the advisory board for Silence Therapeutics; is employed for part-time research for Geisinger; serves as an unpaid trustee for FH Europe; was previously employed at Nemours (July 2018); served as the Medical Director of FH Foundation (May 2018-December 2019); served as a consultant for RegenX Bio; and received research support from the National Institutes of Health for CARDIA (echo reading center), a study of cardometabolic risk and obesity in Down syndrome.

Matthew J. Gurka, PhD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Philip J. Hashkes, MD, receives research grants from BMS; serves as a consultant for Neopharm; serves as a consultant for Quench Bio; and serves as a consultant and receives honoraria and research grants from Novartis.

Emily B. Heikamp, MD, MSc, PhD, holds a patent, U.S. Patent Application No. 61/487,783, May 1, 2014. “Treatment of Autoimmune Disorders and Infections Using Antagonists of SGK1 Activity.”

Ivor D. Hill, MBChB, receives royalties from UpToDate as a chapter author.

Jordan Hupert, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Alan H. Jobe, MD, PhD, patent for Budesonide and surfactant being sought by CCHMC from Chiesi Pharmaceuticals.

Ian Krantz, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

K. Casey Lion, MD, MPH, declares no conflicts of interest, real or perceived, financial or nonfinancial.

David M. Maahs, MD, PhD, serves on the advisory board of and receives research support to his institution from Medtronic and Abbott; serves on the advisory board of Abbott, Novo Nordisk, Eli Lilly, and Dompe; serves as a consultant for Aditxt, Helmsley Charitable Trust, and Sanofi; and his institution receives research support from Dexcom, Tandem, and Roche.

Anthony J. Mancini, MD, serves on the advisory board and as a consultant for Verrica (molluscum), ParaPRO (scabies), Novartis (pediatric psoriasis), Sanofi/Regeneron (atopic dermatitis), and Cassiopea (acne vulgaris).

An Massaro, MD, is employed by Children’s National Hospital; receives research grants from the American Heart Association and the Cerebral Palsy Alliance Research Foundation; serves on the board of directors for the Newborn Brain Society; and is the HIE Focus Group Leader for the Children’s Hospital Neonatal Consortium.

Jane Newburger, MD, MPH, serves as the chair of the Independent Events Adjudication Committee for clinical trials of apixiban in children for Bristol-Myers-Squibb (through a grant to Boston Children’s Hospital); serves as the chair of the Events Adjudication Committee for clinical trials of apixiban for Pfizer (through a grant to Boston Children’s Hospital); serves as the chair of the Events Adjudication Committee for a randomized trial of Entresto (sacubitril/valsartan) in children for Novartis (through a grant to Boston Children’s Hospital); serves as a Study Steering Committee member for Daiichi-Sankyo for a randomized trial of Endoxaban in children; receives research grants from the NIH; and serves on the Editorial Board for Circulation, Annals of Pediatric Cardiology, and Cardiology in the Young.

Jane A. Oski, MD, MPH, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Mary A. Ott, MD, MA, serves on the Adolescent Medicine Subboard for the American Board of Pediatrics; is a member of the Pediatric Research in the Office Setting steering committee for the American Academy of Pediatrics (2018-present); serves on the editorial advisory committee for Perspectives on Sexual & Reproductive Health for the Guttmacher Institute; serves on the Board of Directors for Partnership for Male Youth; receives research grants from the National Institutes of Health; receives a research grant from PCORI; received an Interdisciplinary Research Leaders grant (2017-2020) from the Robert Wood Johnson Foundation; participated on a panel as a paid expert for Merck (2019); served as a paid expert consultant for Bayer, USA (2018); received a research grant from the Society for Family Planning (2016-2019); served on the executive committee for the Section on Bioethics for the American Academy of Pediatrics (2013-2019); and owns stock in and her spouse is employed by Eli Lilly, Inc.

James Padbury, MD, serves on the Editorial Board of Molecular Reproduction and Development.

Rebecca Pellett Madan, MD, MSc, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Richard A. Polin, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.                 

Henry S. Roane, PhD, BCBA-D, is employed by the State University of New York, Upstate Medical University; is an adjunct faculty member of Syracuse University; and serves as a consultant for Modern Clinics (dba Sprout Therapy).

Lainie Friedman Ross, MD, PhD, spouse owns stock in General Electric and Bristol-Myers Squibb.

Marco Aurélio Palazzi Sáfadi, MD, PhD, serves as a consultant for and receives research grants from Pfizer, Sanofi-Pasteur, GlaxoSmithKline, Takeda, and Seqirus; serves as a consultant for Abbvie; serves as an Associate Editor for Jornal de Pediatria (Rio J); serves on the Editorial Board of Pneumonia BMC; and serves as a member of the SAGE Working Group on Meningococcal Vaccines and Vaccination.

Lane Strathearn, MBBS, PhD, is a professor at the University of Iowa; receives R01 and P50 research grants and honoraria for study section review from the National Institutes of Health; receives honoraria from James Cook University, Sun Yat-Sen University (China), and Guangdong International Volunteer Expatriate Service; receives honorarium for Grand Rounds presentation from Indiana University School of Medicine, and serves as an invited Guest Editor for SpringerNature Reviews Journals.

Philip Toltzis, MD, declares no conflicts of interest, real or perceived, financial or nonfinancial.

Jennifer L. Vande Voort, MD, is an employee of Mayo Clinic; serves as a co-PI on an investigator initiated study that has a grant-in-kind for supplies and genotyping only through Assurex Health, Inc; and serves as a review editor for Frontiers in Psychiatry.

Clyde J. Wright, MD, serves on the Editorial Board for Neonatology, Pediatric Medicine, and Neoreviews; his spouse receives consultant fees/honoraria from Abbott Laboratories, American Heart Association, Biosense Webster, Boston Scientific, Biosig, and Medtronic.

Advertisement